Manufacturing biotechnological medicines is a highly specialized activity, and Amgen is a leader in the field. The company’s state-of-the-art biotechnology manufacturing and process development capabilities help us to realize the potential of our pipeline for patients around the world.
Scalable, flexible, and committed to safety and reliability, our capabilities in process development, manufacturing, quality and supply chain management are continually growing. Amgen is continually monitoring capabilities in those areas to meet future needs.
As one of the industry’s original innovators, Amgen has extensive knowledge and first-hand expertise in clinical and commercial manufacturing of biotechnology-based medicines. We have an outstanding track record of regulatory compliance, thanks to stringent controls and a superior quality system. We have world-class capabilities in process development and continually innovate newer and more efficient ways to produce therapies using biotechnology. Most importantly, we have a track record of safely and reliably delivering medicines to patients who need them.